Cancer
New research on stroke rehabilitation has highlighted the potential of machine learning algorithms to personalize and improve the recovery process for stroke survivors. According to a study published in the Journal of Engineering, stroke is a significant global public health challenge, ranking as the second leading cause of death after
Cancer research
A groundbreaking study published in Nature Communications has revealed significant findings on the use of cancer gene therapy in treating acute myeloid leukemia (AML). Researchers at the Fred Hutchinson Cancer Research Center conducted a phase I/II clinical trial, evaluating the safety, persistence, and efficacy of Epstein-Barr virus (EBV)-
Cancer research
A recent study published in the International Journal of Molecular Sciences has highlighted the potential of sodium-glucose cotransporter 2 inhibitors (SGLT2is) in reducing cardiovascular morbidity and mortality in cancer patients. According to the research, patients with active cancer and cancer survivors are at a significantly increased risk of developing cardiovascular
Cancer
Researchers at University Hospital in Madrid, Spain, have reported promising results in using immunotherapy to treat diffuse intrinsic pontine glioma (DIPG) in children. The study, published in the European Journal of Hospital Pharmacy, details the case of three patients who underwent treatment with oncolytic viruses followed by immune checkpoint inhibitors
Cancer
Researchers from the University of Bari Aldo Moro have conducted a review of gene expression changes in cerebral tumors before and after radiotherapy. The study aimed to explore the molecular mechanisms underlying treatment response and potential biomarkers for prognosis and therapeutic targeting. By examining the current literature from 2011 to
Cancer treatment
Sir Ian McGeechan, the legendary British and Irish Lions coach and player, has given a positive update on his prostate cancer diagnosis. In a recent interview with Telegraph Sport, McGeechan revealed that he had received good news about his condition after undergoing six weeks of radiotherapy treatment. Speaking to fellow
Cancer
Cancer researchers have made significant progress in understanding the genetic basis of musculoskeletal sarcomas, a type of rare and heterogeneous malignant tumor affecting both children and adults. According to a recent study published in Exploration of Targeted Anti-tumor Therapy, researchers have identified DNA methylation as a crucial epigenetic mechanism that
Cancer research
Researchers from the First Affiliated Hospital of Ningbo University in Zhejiang, People's Republic of China, have conducted a study to explore the impact of early-nasal intervention on sinusitis caused by radiation therapy in patients with nasopharyngeal carcinoma (NPC). The study, published in the Ear, Nose & Throat Journal,
Cancer research
A recent study published in the JAMA Network Open journal suggests that breast cancer survivors may have an 8% lower risk of developing Alzheimer's disease compared to those without cancer. The study, led by Dr. Su-Min Jeong of Seoul National University, analyzed data from over 70,000 patients
Cancer research
A recent report has highlighted a concerning decline in the uptake of a vaccine that could significantly increase the chances of avoiding one of the most preventable forms of cancer. The human papillomavirus (HPV) vaccine is typically offered to school pupils aged between 12 and 13 to combat the spread
Cancer
Researchers from Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital have recently conducted a study on the efficacy and safety of combining adebrelimab with apatinib and irinotecan for advanced gastric cancer refractory to PD-1 inhibitors. The single-arm, single-centre exploratory trial aimed to evaluate the combination therapy's
Cancer research
MAIA Biotechnology, a clinical-stage biopharmaceutical company, has entered into a clinical master supply agreement with Roche to investigate the combination of its telomere-targeting agent ateganosine and Roche's checkpoint inhibitor atezolizumab for the treatment of hard-to-treat cancers. The partnership aims to strengthen MAIA's mission to find safe
